Ceftin (cefuroxime axetil)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved September 1997

Specific Treatments:

acute bronchitis

General Information

Ceftin (Cefuroxime axetil) has been approved by the U.S. Food and Drug Administration for the treatment of secondary bacterial infections of acute bronchitis with 5-day therapy.